{
  "docId": "019dd923-5e88-73ef-bd5c-fd5012384ae3",
  "docSlug": "bf350dd574c19997",
  "documentTitle": "2021 Air Street Capital The State of AI Report 2021",
  "authorId": "AirStreetCapital",
  "authorName": "Air Street Capital",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "vc_research",
  "sourceTypeLabel": "VC research",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.777,
  "pageNumber": 95,
  "pageCount": 188,
  "prevPage": 94,
  "nextPage": 96,
  "slideType": "case_study",
  "function": "illustrate_case",
  "density": "overcrowded",
  "nDataPoints": 18,
  "notes": "Includes a process flow diagram and comparative bar charts showing efficiency gains.",
  "elementsJson": [
    "paragraph",
    "process_diagram",
    "funnel_chart",
    "bar_chart_stacked"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5e88-73ef-bd5c-fd5012384ae3/95",
  "deckHref": "/decks/019dd923-5e88-73ef-bd5c-fd5012384ae3",
  "deckJsonHref": "/decks/019dd923-5e88-73ef-bd5c-fd5012384ae3.json",
  "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5c-fd5012384ae3#slide-95",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "By conducted targeted exploration of biological search space with compound and disease cell type combinations, the company is building a “map” of disease biology.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd952-47c4-7719-a20a-092dcb9c163c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.15,
        "x": 0.8,
        "y": 0.6
      },
      "kind": "chart",
      "text": "...and go faster",
      "attrs": null,
      "subkind": "bar-stacked",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5ad7989a-84aa-48c2-ab2c-be7d35563897",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.1,
        "x": 0.65,
        "y": 0.6
      },
      "kind": "chart",
      "text": "...spend less",
      "attrs": null,
      "subkind": "bar-stacked",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "beada7d2-b58b-4117-bf4f-fc0680e08a81",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.15,
        "x": 0.45,
        "y": 0.6
      },
      "kind": "chart",
      "text": "Failing faster and earlier to...",
      "attrs": null,
      "subkind": "funnel",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4488a2cc-38f4-4fc8-bfba-55e49956eca9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.4,
        "x": 0.05,
        "y": 0.6
      },
      "kind": "diagram",
      "text": "Process flow of drug discovery from cell reception to microscopy imaging.",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "56b7f479-1075-49f8-881a-e6e8c67ff4ba",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "Drug discovery efficiency: $436M",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd952-47c4-7719-a20a-0e6907a61738",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.9,
        "x": 0.05,
        "y": 0.22
      },
      "kind": "paragraph",
      "text": "Recursion Pharmaceuticals, a Utah-based AI-first company that makes use of high-throughput screening and computer vision-powered microscopy to discover drugs, raised $436M in its NASDAQ IPO in April 2021. The business has 37 internally-developed drug programs including 4 clinical-stage assets. By conducted targeted exploration of biological search space with compound and disease cell type combinations, the company is building a “map” of disease biology. With this map, the company is predicting tens of billions of relationships between disease models and therapeutic candidates. This includes relationships that are predictive of candidate mechanism of action, which expands the discovery funnel beyond hypothesized and human-biased targets.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "32bd9e6b-c7ab-421a-b1e3-44456d344688",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.9,
        "x": 0.05,
        "y": 0.13
      },
      "kind": "title",
      "text": "2020 Prediction: An AI-first drug discovery companies IPOs or is acquired for $1B",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2fb7e9df-2f27-4100-b198-da88bfa350e6",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 152,
      "from": 5,
      "beatId": "019dd95a-0682-776c-8e35-0affbadec38e",
      "arcName": "The Triple Take",
      "arcSlug": "triple-take",
      "beatName": "The Facts (What)",
      "beatSlug": "triple-take-the-facts-what",
      "evidence": "Definitions p.5-6, Exec Summary p.7, then Sections 1-3 catalog evidence.",
      "position": 1,
      "confidence": 78,
      "parentBeatName": "Setup",
      "parentBeatSlug": "setup"
    },
    {
      "to": 152,
      "from": 10,
      "beatId": "019dd95a-0682-776c-8e35-1b3ee3a1c012",
      "arcName": "The Mountain",
      "arcSlug": "mountain",
      "beatName": "Rising Action",
      "beatSlug": "mountain-rising-action",
      "evidence": "Three sections accumulating evidence of accelerating progress.",
      "position": 2,
      "confidence": 55,
      "parentBeatName": "Development",
      "parentBeatSlug": "development"
    }
  ],
  "loops": [
    {
      "to": 97,
      "from": 93,
      "name": "Pattern Hunter",
      "slug": "02-pattern-hunter",
      "bestFor": "Time-pressed audiences, building consensus, when data is strong",
      "matchId": "019dd95a-07fe-70ce-8d3d-6d94b8e8790f",
      "evidence": "Multiple case studies validating the 2020 IPO prediction with applied biology proof.",
      "position": 12,
      "objective": "Show AI delivering in drug discovery",
      "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion",
      "confidence": 78,
      "description": "Group multiple pieces of evidence that together point to a pattern or conclusion"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}